TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Reactive Hyperemia Index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: 5th generation troponin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: MiR-210
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Screen failure rate (percentage)
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Histological clearance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in CERAD-K total score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: Treatment Helpfulness
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Salivary cortisol response to Cold Pressor Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Self-reported Pain (NPRS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Abdominal Adiposity (Waist Circumference)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in Insulin Sensitivity (HOMA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Reduction in relapse episodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lowering a biochemical marker of alcohol intake
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in the Relative Index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Wheelchair mobility skill performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: sequencing of mitochondrial DNA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of improvement in vaginal atrophy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Rate of improvement in sexual function
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Rate of improvement in pain
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Change in Copenhagen Burnout Inventory (CBI) Score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in number of caring errors
Endpoint domain: Adverse events/effects
Primary endpoint: Change in number of medication errors
Endpoint domain: Adverse events/effects
Primary endpoint: Frequency and severity of treatment-emergent adverse events (TEAEs) from vital signs
Endpoint domain: Adverse events/effects
Primary endpoint: Frequency and severity of treatment-emergent adverse events (TEAEs) from 12-lead electrocardiograms (ECGs)
Endpoint domain: Adverse events/effects
Primary endpoint: Frequency and severity of treatment-emergent adverse events (TEAEs) from laboratory test results
Endpoint domain: Adverse events/effects
Primary endpoint: Frequency and severity of treatment-emergent adverse events (TEAEs) from physical examination
Endpoint domain: Adverse events/effects
Primary endpoint: Improvement in developmental trajectory
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Unplanned extubation rate
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of union
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Infant recognition memory
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postnatal infant weight gain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Postnatal growth in infant head circumference
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Methylation age clock testing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Telomere Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Denture Plaque Index (DPI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Variation in pro-diabetes inflammation markers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in Aberrant Behavior Checklist (ABC-C)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Cadence (number of steps per minute)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Walk ratio (stride length / cadence)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Verbal paired associates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Number of genes predictive of response at Baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Number of genes predictive of response at 24 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Proportion of participants with a change in clonal expansion of T cells associated with response to anti-PD-1 therapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Rate of adverse events (AEs)/ serious adverse events (SAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Global Cognitive Ability
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Feasibility of conducting the intervention
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Acceptability of each cooking class
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Cognitive scale
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Motivation scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Engagement Scale
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Difference in GRASSP V2 score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Difference in GRASSP-M score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Aqueous Biomarkers of the Blood Metabolome
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Lipid Biomarkers of the Blood Metabolome
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Biomarkers on the Urine Metabolome
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Fusion rate at 6 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: pinchmeter
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: painful feelings
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Immunogenicity against Wuhan
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Immunogenicity against Omicron BA.1
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Safety and tolerability of PHH-1V
Endpoint domain: Adverse events/effects
Primary endpoint: Stem subsidence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percent adherence to recommended number of exercises
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change in the MD Anderson Dysphagia Inventory (MDADI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: change in eczema severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Change in hematocrit value
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Parental Emotion Dysregulation
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Parenting Quality (Total Dysfunctional Discipline)
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Number of Participants with Adverse Event of Special Interest (AESIs)
Endpoint domain: Adverse events/effects
Primary endpoint: ADAS-Cog-Plus-EF&FA Battery Total Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Diagnostic performance of gadobenate dimeglumine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quantitative measures of hepatobiliary phase images
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Preference of radiologists for images
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Percentage of Maternal Participants Reporting Local Reactions Within 7 Days After Dose 1
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of Maternal Participants Reporting Systemic Events Within 7 Days After Dose 1
Endpoint domain: Adverse events/effects
Primary endpoint: Geometric Mean Ratio (GMR) of the SARS-CoV-2 Neutralizing Titers in Pregnant Women to Those in Nonpregnant Women
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Incidence and Severity of Treatment-emergent Adverse Events (TEAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Safety of implant placement
Endpoint domain: Adverse events/effects
Primary endpoint: Efficacy of Sildenafil doses versus placebo - IIEF-EF
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Efficacy of Sildenafil doses versus placebo - SEP Question 2
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Efficacy of Sildenafil doses versus placebo - SEP Question 3
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of clients screened for chronic pain and opioid misuse/opioid use disorder
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Numerical Pain Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: CRPS pain
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Functionality/physical abilities
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Subject-rated global impression of change
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Duration of osteotomy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: MicroRNA 21 (Mir-21) expression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients with a left atrial thrombus
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Positive predictive value of acute cardiac CT compared to TEE
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Montgomery Asberg Depression Rating Scale (MADRS) Rate of Response
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: graft taking
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Therapeutic alliance of patients
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Motivation of patients
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Longitudinal trajectory of treatment adherence
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Longitudinal trajectory of symptom severity for mental health
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Suicide and self-harm
Endpoint domain: Adverse events/effects
Primary endpoint: Presence of demodex mites
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Lumbar anterior flexion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Revised Oswestry Pain Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: C Reactive Protein
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Interleukin-8
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in number of dispensed opioid prescriptions
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Days out-of-hospital
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Change in Patient Reported Splint Evaluation Questionnaire (PRSEQ)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Adverse drug reactions/adverse events/serious adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Change in Oswestry disability index (ODI)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change in Dynamic compensation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Procollagen Type 1 N-terminal propeptide (P1NP) Levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: American knee society knee score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: the knee injury and osteoarthritis score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Visual Analog Score for pain
Endpoint domain: Life impact
Endpoint subdomain: Pain
Primary endpoint: Syringe Sharing
Endpoint domain: Adverse events/effects
Primary endpoint: Sex Without Condom
Endpoint domain: Adverse events/effects
Primary endpoint: Sensorial Assessment-2
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Balance Assessment-1
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Balance Assessment-2
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Walking Speed Assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of participants who experienced adverse events (AEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of participants who prematurely discontinued treatment due to adverse events (AEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of participants with ≥1 log10 IU/mL decline from baseline in quantitative HBsAg (qHBsAg) after SLGN treatment at Week 24
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Self-sufficiency
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Number of subjects with Protocol Specified Dose-Limiting Toxicities
Endpoint domain: Adverse events/effects
Primary endpoint: Number of subjects with dose interruptions, reductions, and doses administered
Endpoint domain: Adverse events/effects
Primary endpoint: Stiffness of the breasts
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Risk and malignancies lesions (RnMLs)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Number of Oral Ulcers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Number of Genital Ulcers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Pneumococcal carriage prevalence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Volumetric fraction of renal cortex with increased perfusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Time to first occurrence of disease progression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Stage improvement in fibrosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Child emotional/behavioural problems
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Intensive Care Unit admission
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: LH value
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: IBS Severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Single leg standing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Energy used per stone volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Kinetics of force waves
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 5 kilometer cycling time trial
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 5 kilometer Time trial performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: improvement in the degree of asthma control
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Interval Time for Changing the Fixation Strap
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Times of Adjusting the Catheter Position
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Effectiveness of skin management
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Incidence of Ineffective Oxygenation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Intubation condition
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Minute Ventilation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Delayed recall of words
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: blood loss during cesarean section
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Number of rehabilitation sessions for optimal function
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Reliability of ultrasonography and MRI for detection of Morton neuroma
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Specificity of ultrasonography and MRI for detection of Morton neuroma
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: normative reference values for blood pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Number of Unsolicited Adverse Events (AEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Change in integrity of the contralateral corticospinal tract fibers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in functional arm movements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in functional gross and fine motor coordination
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Live LcS Numbers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in time and resources for offline plan adaptation
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Improvements in radiation dosimetry from using online adaptation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of participants that report using PrEP
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Number of Dried Blood Spot (DBS) tests that report PrEP use
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Number of participants that bring a proof of PrEP prescription
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Type-2 signature parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Needs-based quality of life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change in self-reported fatigability level
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Western Ontario McMaster Universities Arthritis Index (WOMAC)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Straining with first postoperative bowel movement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Number of participants with new or persistent symptoms after COVID-19
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Health-related quality of life before and after presenting COVID-19
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Mental health symptoms before and after presenting COVID-19
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in Subjective Rating of Symptoms at 2 Weeks
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in Cognitive Function at 2 Weeks
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Cancer reappearance
Endpoint domain: Mortality/survival
Primary endpoint: Individual heat stress
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Participant household temperature
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Participant hydration level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Timeline Followback
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Modified Colorado Symptom Index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: superiority of Regugolix combination therapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Brief Symptom Rating Scale (BSRS-5)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Perception Threshold
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes